Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study DOI

Jaycie Koh,

Ayman Mohamed, Gwyneth Kong

et al.

Diabetes Obesity and Metabolism, Journal Year: 2024, Volume and Issue: 27(2), P. 683 - 696

Published: Nov. 11, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value MASLD, across body weight categories, in a secondary preventative acute myocardial infarction (AMI) cohort.

Language: Английский

Targeting Metabolic Diseases with Celastrol: A Comprehensive Review of Anti-Inflammatory Mechanisms and Therapeutic Potential DOI

Xiaojuan Wang,

Mohamad Hafizi Abu Bakar,

Liqun Song

et al.

Journal of Ethnopharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 119560 - 119560

Published: Feb. 1, 2025

Language: Английский

Citations

0
Young-onset chronic kidney disease in Mexico: Secondary analysis of global burden of disease study, 1990–2019 DOI
Claudio Alberto Dávila-Cervantes, Marcela Agudelo‐Botero

Preventive Medicine, Journal Year: 2024, Volume and Issue: 181, P. 107901 - 107901

Published: Feb. 20, 2024

Language: Английский

Citations

2
Exposure to outdoor artificial light at night increases risk and burden of metabolic disease in Ningxia, China DOI
Huihui Wang,

Xiaohong Ma,

Zhenfan Yu

et al.

Environmental Science and Pollution Research, Journal Year: 2023, Volume and Issue: 30(37), P. 87517 - 87526

Published: July 10, 2023

Language: Английский

Citations

4
Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors DOI

Vickram Vijay Anand,

Jaycie Koh,

Tian-Seng Teo

et al.

Clinical Research in Cardiology, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 12, 2024

Language: Английский

Citations

1
Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study DOI

Jaycie Koh,

Ayman Mohamed, Gwyneth Kong

et al.

Diabetes Obesity and Metabolism, Journal Year: 2024, Volume and Issue: 27(2), P. 683 - 696

Published: Nov. 11, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value MASLD, across body weight categories, in a secondary preventative acute myocardial infarction (AMI) cohort.

Language: Английский

Citations

0